Phibro Animal Health Corporation P/E Ratio 2012–2025
Phibro Animal Health Corporation reported 21.09 of price-to-earnings ratio for fiscal 2025. That was 92.1% lower than fiscal 2024. Compared with fiscal 2020, the change was -22.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 21.09 | -92.1% |
| FY 2024 | 268.38 | +1616.3% |
| FY 2023 | 15.64 | +9.8% |
| FY 2022 | 14.25 | -24.7% |
| FY 2021 | 18.91 | -30.4% |
| FY 2020 | 27.16 | +37.2% |
| FY 2019 | 19.81 | -16.7% |
| FY 2018 | 23.78 | +25.3% |
| FY 2017 | 18.98 | +158.9% |
| FY 2016 | 7.33 | -64.4% |
| FY 2015 | 20.61 | — |
| FY 2014 | — | — |
| FY 2013 | — | — |
| FY 2012 | — | — |
Source: Phibro Animal Health Corporation SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open PAHC 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Phibro Animal Health Corporation reported 21.09 of price-to-earnings ratio for fiscal 2025. That was 92.1% lower than fiscal 2024. Compared with fiscal 2020, the change was -22.4%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Phibro Animal Health Corporation
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freePhibro Animal Health Corporation — frequently asked questions
What is Phibro Animal Health Corporation's price-to-earnings ratio?
Phibro Animal Health Corporation (PAHC) reported price-to-earnings ratio of 21.09 for fiscal year 2025, per its SEC filings.
How has Phibro Animal Health Corporation's price-to-earnings ratio changed over time?
Between fiscal 2012 and 2025, PAHC's price-to-earnings ratio grew at roughly 0.2% per year (compound annual rate), from 20.61 to 21.09.
Where does this data come from?
Figures are computed from Phibro Animal Health Corporation's official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More PAHC financial history
Full PAHC fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →